Gas, NaturalTaxesHealth Care ReformGene Products, taxIncome TaxHuman T-lymphotropic virus 1Tax ExemptionPoliticsNational Health Insurance, United StatesGenes, pXUniversal CoverageFederal GovernmentPatient Protection and Affordable Care ActHuman T-lymphotropic virus 2United StatesInsurance, HealthFinancing, GovernmentHTLV-I InfectionsCost ControlPublic PolicyHealth PolicyPrivatizationState Health PlansHealth Care SectorLeukemia-Lymphoma, Adult T-CellState GovernmentHealthcare FinancingBudgetsPolicy MakingNational Health ProgramsEconomic CompetitionCommerceTranscriptional ActivationHealth Benefit Plans, EmployeeHealth ExpendituresCompetitive Medical PlansDelivery of Health CarePublic OpinionGovernment RegulationLabor UnionsSocial WelfareMedically UninsuredHealth Services AccessibilityInsurance PoolsAccountable Care OrganizationsInsurance CoverageCyclic AMP Response Element-Binding ProteinJurkat CellsLeukemia Virus, BovineManaged CompetitionGene Expression Regulation, ViralReimbursement MechanismsTerminal Repeat SequencesMedicaidLiability, LegalPrivate SectorEfficiency, Organizational